262 related articles for article (PubMed ID: 125463)
1. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
Iwamoto M
Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
Longstaff C
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
[TBL] [Abstract][Full Text] [Related]
3. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
4. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
6. Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
Ho-Tin-Noé B; Rojas G; Vranckx R; Lijnen HR; Anglés-Cano E
FEBS J; 2005 Jul; 272(13):3387-400. PubMed ID: 15978044
[TBL] [Abstract][Full Text] [Related]
7. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
Bangert K; Thorsen S
Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
[TBL] [Abstract][Full Text] [Related]
8. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
9. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin.
Abiko Y; Iwamoto M
Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764
[No Abstract] [Full Text] [Related]
11. Interaction of plasmin with tranexamic acid and alpha 2 plasmin inhibitor in the plasma and clot.
Takada A; Ito T; Takada Y
Thromb Haemost; 1980 Feb; 43(1):20-3. PubMed ID: 6447383
[TBL] [Abstract][Full Text] [Related]
12. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
13. [Plasminogen-binding centers of molecules of fibrinogen, fibrin and products of their proteolysis].
Grinenko TV; Tret'iachenko VG; Kudinov SA; Medved' LV
Biokhimiia; 1987 Oct; 52(10):1732-9. PubMed ID: 3427134
[TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
Wu JH; Diamond SL
J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
[TBL] [Abstract][Full Text] [Related]
15. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
16. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
Takada A; Takada Y
Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid, an inhibitor of plasminogen activation, aggravates staphylococcal septic arthritis and sepsis.
Kłak M; Anäkkälä N; Wang W; Lange S; Jonsson IM; Tarkowski A; Jin T
Scand J Infect Dis; 2010 May; 42(5):351-8. PubMed ID: 20100112
[TBL] [Abstract][Full Text] [Related]
19. [Binding of Glu-plasminogen by fibrinogen and byproducts of its proteolysis].
Grinenko TV; Tret'iachenko VG; Skomorovskaia EV; Kudinov SA
Biokhimiia; 1989 Feb; 54(2):213-20. PubMed ID: 2525932
[TBL] [Abstract][Full Text] [Related]
20. Different assessment of plasmin with different substrates. In vitro alteration of plasmin, influence of epsilon-aminocaproic acid and tranexamic acid upon its activity.
Lämmle B; Duckert F
Thromb Haemost; 1980 Jun; 43(2):112-7. PubMed ID: 6450467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
